Supercharging CAR-T cells for cancer treatment.

Before CAR-T therapy really picks up steam toward its full life-saving potential, society might see one or more major improvements in its cost or effectiveness. Here’s one: “Traditional CAR-T cells, while effective against liquid cancers, face challenges in solid tumors—the cells wear themselves out and ultimately failing to destroy the cancer fully. Professor Tang’s research introduces CAR-T cells that excrete the IL-10 molecule, which is then ingested by the modified T cells. In other words, the cell has been engineered to produce its own medicine to keep healthy in the tumor’s hostile environment.” ~ learn more